Ping Lin

668 total citations
27 papers, 466 citations indexed

About

Ping Lin is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Ophthalmology. According to data from OpenAlex, Ping Lin has authored 27 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Ophthalmology. Recurrent topics in Ping Lin's work include Prostate Cancer Treatment and Research (9 papers), Cancer, Lipids, and Metabolism (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Ping Lin is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Cancer, Lipids, and Metabolism (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Ping Lin collaborates with scholars based in China, United States and United Kingdom. Ping Lin's co-authors include Andrew J. Armstrong, Tomasz M. Beer, Bertrand Tombal, Teresa Parli, Weina Wang, Yuqian Wang, Yusen Huang, Paul Harmatz, Celestia S. Higano and Steve van Os and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and European Urology.

In The Last Decade

Ping Lin

22 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Lin China 11 218 125 105 88 84 27 466
Seth Kaufman United States 12 93 0.4× 116 0.9× 17 0.2× 38 0.4× 31 0.4× 19 678
Felipe D’Almeida Costa Brazil 13 159 0.7× 19 0.2× 16 0.2× 14 0.2× 12 0.1× 64 487
Pei‐Wei Huang Taiwan 10 77 0.4× 49 0.4× 17 0.2× 26 0.3× 11 0.1× 30 319
Anna Felis‐Giemza Poland 10 26 0.1× 26 0.2× 20 0.2× 25 0.3× 40 0.5× 52 474
William Godfrey United States 11 44 0.2× 55 0.4× 36 0.3× 194 2.2× 15 0.2× 16 392
Gowri L. Kanthan Australia 15 243 1.1× 305 2.4× 13 0.1× 314 3.6× 16 0.2× 20 689
S Banavali India 10 39 0.2× 18 0.1× 18 0.2× 66 0.8× 244 2.9× 25 497
P. Cathcart United Kingdom 9 241 1.1× 45 0.4× 27 0.3× 3 0.0× 39 0.5× 34 613
Linda Hershon Canada 12 146 0.7× 10 0.1× 29 0.3× 10 0.1× 19 0.2× 15 437

Countries citing papers authored by Ping Lin

Since Specialization
Citations

This map shows the geographic impact of Ping Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Lin more than expected).

Fields of papers citing papers by Ping Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Lin. The network helps show where Ping Lin may publish in the future.

Co-authorship network of co-authors of Ping Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Lin. A scholar is included among the top collaborators of Ping Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Lin. Ping Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Ping, et al.. (2024). Association between sarcopenia and hemoglobin level: a systematic review and meta-analysis. Frontiers in Medicine. 11. 1424227–1424227. 4 indexed citations
2.
Chen, Min, et al.. (2024). Phototherapeutic keratectomy for corneal epithelial-stromal dystrophies in pediatric patients. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(11). 3725–3728.
3.
Lin, Ping, et al.. (2024). Chordoma combined with Trousseau syndrome: a case report and literature review. Journal of Thoracic Disease. 16(9). 6249–6262.
4.
Lin, Ping, et al.. (2024). Urokinase in the treatment of tuberculous pleurisy: a systematic review and meta-analysis. BMC Infectious Diseases. 24(1). 258–258. 2 indexed citations
5.
Lin, Ping, et al.. (2024). Switching to the aflibercept (3 mg) therapy for treatment-resistant wet age-related macular degeneration: 1-year outcomes. Medicine. 103(16). e37839–e37839. 2 indexed citations
6.
Joshua, Anthony M., Andrew J. Armstrong, Megan Crumbaker, et al.. (2022). Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER. European Journal of Cancer. 170. 285–295. 21 indexed citations
7.
Dong, Yanling, Dongfang Li, Ping Lin, et al.. (2022). Dissecting the Profile of Corneal Thickness With Keratoconus Progression Based on Anterior Segment Optical Coherence Tomography. Frontiers in Neuroscience. 15. 804273–804273. 10 indexed citations
8.
Armstrong, Andrew J., Ping Lin, Bertrand Tombal, et al.. (2020). Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial. European Urology. 78(3). 347–357. 101 indexed citations
9.
Xu, Haifeng, et al.. (2019). Long-Term Efficacy of Intravitreal Conbercept Injection in the Treatment of Idiopathic Choroidal Neovascularization. Journal of Ocular Pharmacology and Therapeutics. 36(2). 116–121. 4 indexed citations
10.
Armstrong, Andrew J., Mohammed Al-Adhami, Ping Lin, et al.. (2019). Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide. JAMA Oncology. 6(2). 217–217. 16 indexed citations
11.
Armstrong, Andrew J., Ping Lin, Celestia S. Higano, et al.. (2018). Prognostic Association of Prostate-specific Antigen Decline with Clinical Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide in a Randomized Clinical Trial. European Urology Oncology. 2(6). 677–684. 25 indexed citations
12.
13.
Siemens, D. Robert, Laurence Klotz, Axel Heidenreich, et al.. (2017). Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial. The Journal of Urology. 199(1). 147–154. 29 indexed citations
14.
15.
Quartel, Adrian, et al.. (2014). Growth Charts for Individuals with Mucopolysaccharidosis VI (Maroteaux–Lamy Syndrome). JIMD Reports. 18. 1–11. 31 indexed citations
16.
Giugliani, Roberto, Christina Lampe, Nathalie Guffon, et al.. (2014). Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux–Lamy syndrome)—10‐year follow‐up of patients who previously participated in an MPS VI survey study. American Journal of Medical Genetics Part A. 164(8). 1953–1964. 68 indexed citations
17.
Quartel, Adrian, et al.. (2014). Growth charts for individuals with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Molecular Genetics and Metabolism. 111(2). S88–S89. 7 indexed citations
18.
Xu, Haifeng, Ying Liang, Ping Lin, & Jie Wu. (2012). Optical Coherence Tomography for Multifocal Vitelliform Macular Dystrophy. Optometry and Vision Science. 90(1). 94–99. 2 indexed citations
19.
Xu, Haifeng & Ping Lin. (2011). Unilateral recurrent acute idiopathic maculopathy. Graefe s Archive for Clinical and Experimental Ophthalmology. 249(6). 941–944. 7 indexed citations
20.
Shi, Weiyun, et al.. (2005). Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis. Graefe s Archive for Clinical and Experimental Ophthalmology. 244(4). 492–497. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seth Kaufman Breakdown of academic impact, for papers by Felipe D’Almeida Costa Breakdown of academic impact, for papers by Pei‐Wei Huang Breakdown of academic impact, for papers by Anna Felis‐Giemza Breakdown of academic impact, for papers by William Godfrey Breakdown of academic impact, for papers by Gowri L. Kanthan Breakdown of academic impact, for papers by S Banavali Breakdown of academic impact, for papers by P. Cathcart Breakdown of academic impact, for papers by Linda Hershon
Rankless by CCL
2026